Filter Results
:
(1,639)
Show Results For
-
All HBS Web
(1,639)
- People (7)
- News (488)
- Research (758)
- Events (3)
- Multimedia (9)
- Faculty Publications (361)
Show Results For
-
All HBS Web
(1,639)
- People (7)
- News (488)
- Research (758)
- Events (3)
- Multimedia (9)
- Faculty Publications (361)
- Web
Rare Disease Day – Small Numbers, Big Challenges… and Big Opportunities - Blog: Health Supplement
Topics Biotech/pharma Care Delivery Clinical Trials Digital Health Global Health Health Care Entrepreneurship View Details
- 09 Jun 2020
- Cold Call Podcast
In a Pandemic, What’s the Best Strategy for the Global Vaccine Alliance?
- Web
Men’s Discomfort with Women’s Health Starves Tech Companies Serving Female Customers - Blog: RaGE Report
Companies Serving Female Customers HBS Staff Author HBS Staff This piece was written in collaboration with The Institute for Business in Global Society. (copy credit: Liz Szabo) Although the women’s health...
View Details
- February 2015 (Revised November 2015)
- Supplement
Building an Integrated Biopharma Company: Crucell (B)
By: Richard G. Hamermesh, Marianne Van Der Steen and Susan Harmeling
The Crucell (B) case updates events at Crucell since 2009. In September, 2009, Johnson & Johnson acquired 18% of Crucell for $400 million. This investment was part of a business development deal. Subsequently, in 2012, Johnson & Johnson acquired Crucell for $2.8...
View Details
Keywords:
Biotechnology;
Biopharmacy Company;
Licensing Agreements In Biopharmacy;
Licensing;
Human Cell-line Technology;
Vaccine;
Healthcare Innovation;
Global Health;
Entrepreneurship;
Health Care and Treatment;
Acquisition;
Innovation and Invention;
Biotechnology Industry;
Pharmaceutical Industry
Hamermesh, Richard G., Marianne Van Der Steen, and Susan Harmeling. "Building an Integrated Biopharma Company: Crucell (B)." Harvard Business School Supplement 815-086, February 2015. (Revised November 2015.)
- Web
Bringing the Next Pandemic Vaccine to Your Doorstep with MIMIX - Blog: Health Supplement
Topics Biotech/pharma Care Delivery Clinical Trials Digital Health Global Health Health Care Entrepreneurship View Details
- January 2022
- Article
Global Behaviors, Perceptions, and the Emergence of Social Norms at the Onset of the COVID-19 Pandemic
By: Lukas Hensel, Marc Witte, Stefano Caria, Thiemo Fetzer, Stefano Fiorin, Friedrich M. Goetz, Margarita Gomez, Johannes Haushofer, Andriy Ivchenko, Gordon T. Kraft-Todd, Elena Reutskaja, Christopher Roth, Erez Yoeli and Jon M. Jachimowicz
We conducted a large-scale survey covering 58 countries and over 100,000 respondents between late March and early April 2020 to study beliefs and attitudes towards citizens' and governments' responses at the onset of the COVID-19 pandemic. Most respondents reported...
View Details
Keywords:
COVID-19;
Government Regulation;
Social Norms;
Health Pandemics;
Governing Rules, Regulations, and Reforms;
Behavior;
Perception;
Global Range;
Surveys
Hensel, Lukas, Marc Witte, Stefano Caria, Thiemo Fetzer, Stefano Fiorin, Friedrich M. Goetz, Margarita Gomez, Johannes Haushofer, Andriy Ivchenko, Gordon T. Kraft-Todd, Elena Reutskaja, Christopher Roth, Erez Yoeli, and Jon M. Jachimowicz. "Global Behaviors, Perceptions, and the Emergence of Social Norms at the Onset of the COVID-19 Pandemic." Journal of Economic Behavior & Organization 193 (January 2022): 473–496.
- October 2019 (Revised December 2019)
- Case
La Roche-Posay: Growing L'Oreal's Active Cosmetics Brand
By: Jill Avery, Vincent Dessain and Mette Fuglsang Hjortshoej
As 2018 neared its end, Laetitia Toupet, international general manager of L’Oréal’s La Roche-Posay brand reflected on the brand’s achievements over the past year. At €1 billion in revenue, La Roche-Posay had recently become the number one dermocosmetics brand in the...
View Details
Keywords:
Branding;
Brand Management;
Consumer Products;
Brand Positioning;
Target Market;
Global Brands;
Global Marketing;
Marketing;
Marketing Strategy;
Brands and Branding;
Globalized Firms and Management;
Health Industry;
Health Industry;
Health Industry;
France;
Europe;
Brazil;
China;
Asia;
South America;
United States;
North America
Avery, Jill, Vincent Dessain, and Mette Fuglsang Hjortshoej. "La Roche-Posay: Growing L'Oreal's Active Cosmetics Brand." Harvard Business School Case 520-035, October 2019. (Revised December 2019.)
- May 2009
- Teaching Note
The World Food Programme during the Global Food Crisis (TN) (A) and (B)
By: Eric D. Werker
Teaching Note for [709024] and [709052].
View Details
- September–October 2020
- Article
Global Supply Chains in a Post-Pandemic World: Companies Need to Make Their Networks More Resilient. Here's How.
By: Willy C. Shih
The COVID-19 pandemic exposed the vulnerabilities in the production strategies and supply chains of firms everywhere. Coupled with a rise in economic nationalism, manufacturers everywhere are going to be under pressure to rethink their sourcing and logistics...
View Details
Keywords:
Resilience;
Pandemic;
Operations Management;
Health Pandemics;
Supply Chain;
Supply Chain Management;
Manufacturing Industry;
United States;
Asia;
Europe
Shih, Willy C. "Global Supply Chains in a Post-Pandemic World: Companies Need to Make Their Networks More Resilient. Here's How." R2005F. Harvard Business Review 98, no. 5 (September–October 2020): 82–89.
- September 2020
- Article
Regulatory Sandboxes: A Cure for mHealth Pilotitis?
By: Abhishek Bhatia, Rahul Matthan, Tarun Khanna and Satchit Balsari
Mobile health (mHealth) and related digital health interventions in the past decade have not always scaled globally as anticipated earlier despite large investments by governments and philanthropic foundations. The implementation of digital health tools has suffered...
View Details
Keywords:
COVID-19;
mHealth;
Digital Health;
Design Thinking;
Regulation;
Intervention;
Regulatory Sandbox;
Health Care and Treatment;
Technological Innovation;
Design;
Governing Rules, Regulations, and Reforms;
India
Bhatia, Abhishek, Rahul Matthan, Tarun Khanna, and Satchit Balsari. "Regulatory Sandboxes: A Cure for mHealth Pilotitis?" Journal of Medical Internet Research 22, no. 9 (September 2020).
- February 2015 (Revised November 2015)
- Case
Building an Integrated Biopharma Company: Crucell (A)
By: Richard G. Hamermesh, Marianne Van Der Steen and Susan S. Harmeling
By 2009, Crucell had become the largest biopharma company in the Netherlands and a symbol of national pride. The case traces the evolution of the company from a University spin-off into a fully-integrated company. Crucell's success, particularly in the vaccine space,...
View Details
Keywords:
Biotechnology;
Biopharmacy Company;
Licensing;
Licensing Agreements In Biopharmacy;
Human Cell-line Technology;
Vaccine;
Healthcare Innovation;
Global Health;
Partners and Partnerships;
Entrepreneurship;
Growth and Development Strategy;
Biotechnology Industry;
Pharmaceutical Industry;
Netherlands
Hamermesh, Richard G., Marianne Van Der Steen, and Susan S. Harmeling. "Building an Integrated Biopharma Company: Crucell (A)." Harvard Business School Case 815-085, February 2015. (Revised November 2015.)
- 23 Jun 2020
- Working Paper Summaries
Dignity, Inequality, and the Populist Backlash: Lessons from America and Europe for a Sustainable Globalization
Keywords:
by Rawi Abdelal
- May 2014 (Revised March 2017)
- Case
Unilever's Lifebuoy in India: Implementing the Sustainability Plan
Unilever's new Global Brand VP must not only revitalize Lifebuoy soap's sagging market performance, but simultaneously impact the health of one billion people worldwide. The latter challenge comes from Unilever's new CEO who has introduced the Unilever Sustainable... View Details
Keywords:
Multinational Management;
Corporate Social Responsibility;
Strategy Implementation;
Marketing Strategy;
Mission And Purpose;
Change Management;
International Business;
Global;
Fast-moving Consumer Goods;
Soap;
Corporate Social Responsibility and Impact;
Health Care and Treatment;
Environmental Sustainability;
Global Strategy;
Developing Countries and Economies;
Beauty and Cosmetics Industry;
Health Industry;
India
Bartlett, Christopher A. "Unilever's Lifebuoy in India: Implementing the Sustainability Plan." Harvard Business School Case 914-417, May 2014. (Revised March 2017.)
- Web
Helping & harnessing business to address society's greatest challenges. | Institute for Business in Global Society
Center for Entrepreneurship is a vital resource to HBS students and a champion for entrepreneurship at HBS. Health Care Initiative With global health care spending greater than...
View Details
- Web
THE VALUE OF THE PHYSICIAN SHADOW PROGRAM: Witnessing The Front Lines of Care Delivery - Blog: Health Supplement
Topics Biotech/pharma Care Delivery Clinical Trials Digital Health Global Health Health Care Entrepreneurship View Details
- May 2015 (Revised May 2017)
- Case
Colgate-Palmolive Company: Marketing Anti-Cavity Toothpaste
By: John A. Quelch and Margaret L. Rodriguez
In October 2013, Colgate-Palmolive Company, the world's leading oral care company, was about to launch its new Colgate® Maximum Cavity Protection™ plus Sugar Acid Neutralizer™ toothpaste in Brazil. Oral care category accounted for 46 percent of Colgate's $17.4 billion...
View Details
Keywords:
New Product Management;
Consumer Segmentation;
Global Marketing;
Corporate Social Responsibility;
Healthcare;
Sustainability;
Health Care and Treatment;
Environmental Sustainability;
Marketing;
Segmentation;
Product Development;
Product Launch;
Corporate Social Responsibility and Impact;
Product Positioning;
Consumer Products Industry;
Brazil;
United States
Quelch, John A., and Margaret L. Rodriguez. "Colgate-Palmolive Company: Marketing Anti-Cavity Toothpaste." Harvard Business School Case 515-050, May 2015. (Revised May 2017.)
- Web
Big Pharma has a model to make a profit and save lives. So, what’s the hold-up? - Blog - Business in Global Society
sustainable way to forge and maintain new cross-sector and cross-border partnerships needed to execute the model, and Adding a new layer of knowledge about how pharmaceutical companies handle global public View Details
- Teaching Interest
Business Opportunties in Climate Adaptation
By: John D. Macomber
This is a Short Intensive Program or SIP at Harvard Business School. It’s an optional student offering prior to the formal start of the Spring semester the following week. SIPs tend to cover new material on current topics, to be less formal than the HBS Case Study... View Details
- Web
Women in Leadership, Legacy, and Global Equity: A Conversation with HBS Alumnae Selena Cuffe and Janelle James - Blog: RaGE Report
RaGE Report RaGE Report Ideas for Those Outraged by Inequality Filter Results Arrow Down Arrow Up Read posts from Author HBS Staff Industries Industries Education Filters Read posts from Author HBS Staff Industries Industries Education 15 Mar 2024 Women in Leadership,...
View Details